Trip Sitters & Psychedelic Guides in Louisiana
We Provide Trip Sitting & Guiding Services in Every Major City
- New Orleans
- Baton Rouge
- Shreveport
- Metairie
- Lafayette
- Lake Charles
- Kenner
- Bossier City
- Monroe
- Alexandria
- Prairieville
- Houma
- Marrero
- Central
- Laplace
This list is not meant to be exhaustive. We provide our trip sitting and guiding services in all major cities in Louisiana, including those which are not listed above. If we can physically get ourselves to you, we will sit for you. If you are curious whether we are able to service your area specifically, please contact us.
Substances We Sit With
The one caveat to us being able to provide trip sitting and guiding services is that we cannot provide your substance of choice for personal consumption—we are unable to help with sourcing. Please understand that psychedelics are still federally controlled substances and you assume all the risk associated with possessing and consuming these medicines.
We are here to facilitate intentional psychedelic experiences where you feel supported along the entire journey—from preparation to sacred ceremonial experience to integration. We facilitate your inner healing by holding a safe, comfortable, non-judgmental space.
- Psilocybin
- Ayahuasca
- Mescaline
- Ketamine
- MDMA/MDA
- Cannabis
- DMT
- LSD
**Psychedelic Passage does not provide psychoactive or controlled substances nor are we licensed therapists, counselors, or medical professionals. We are a harm reduction company offering trip sitting & integration coaching services.**
Psychedelic Reform in Louisiana
We are in the midst of a psychedelic renaissance and the legal status of psychedelic substances is evolving rapidly. As of the time of publishing, Indiana has not yet established any psychedelic reform initiatives. However, Dr. Charles Nichols from Louisiana State University Health New Orleans is pioneering the state’s research into psychedelic drugs.
His study found that although psychedelics produce profound behavioral and perceptual changes, they directly activate only about 5% of brain cells. These findings demonstrate how psychedelic activation represents a complex interaction between distinct cell type subsets, instead of the prior belief that psychedelics activate only one specific brain region.
For the purposes of his research, Dr. Nichols developed a new method for organizing brain cells using specific antibodies. Though Louisiana hasn’t seen much traction on psychedelic reform, it seems the state’s scientific minds are growing curious about these substances, ready to develop new methods for investigating the therapeutic potential of psychedelic medicine.
